Literature DB >> 7931824

NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study.

A Sawan1, I Lascu, M Veron, J J Anderson, C Wright, C H Horne, B Angus.   

Abstract

The nm23 gene was originally identified by Steeg et al. by screening of cDNA libraries from murine melanoma cell lines of varying metastatic potential. An inverse relationship between metastatic potential and nm23 RNA and/or protein was found in four different metastatic model systems. It was proposed that nm23 may function as a suppressor gene for tumour metastasis. It has recently been found that the sequence of nm23 and NDP-kinase (NDP-K) is identical. Using an immunohistochemical technique and employing a polyclonal antibody to purified NDP-K A, we have determined NDP-K expression in a series of 197 breast carcinomas. One hundred and sixty (81.2 per cent) of these tumours were scored positive for NDP-K and 37 (18.8 per cent) scored negative. No relationship was found between NDP-K/nm23 expression and patient relapse or survival. Furthermore, no relationship was found between NDP-K/nm23 expression and a number of other prognostic factors including tumour grade, oestrogen receptor, progesterone receptor, and p53 expression. Our results contradict the hypothesis concerning the possible role of NDP-K/nm23 as a metastatic suppressor gene in human breast cancer, but further studies using antibodies specific for NDP-K/nm23 subtypes are clearly indicated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931824     DOI: 10.1002/path.1711720107

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

Review 1.  Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis.

Authors:  Iain L O Buxton; Nucharee Yokdang; Robert M Matz
Journal:  Cancer Lett       Date:  2010-05-28       Impact factor: 8.679

2.  Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal carcinomas. An immunohistochemical study.

Authors:  R Holm; G Tanum
Journal:  Virchows Arch       Date:  1996-05       Impact factor: 4.064

3.  Immunohistochemical detection of nm23/NDP kinase and cathepsin D in medullary carcinomas of the thyroid gland.

Authors:  R Holm; J Høie; O Kaalhus; J M Nesland
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 4.  Genetic analysis of breast cancer progression.

Authors:  S H Dairkee; H S Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

Review 5.  Nm23/nucleoside diphosphate kinase in human cancers.

Authors:  M T Hartsough; P S Steeg
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

6.  Immunohistochemical localization of the NM23 protein in salivary gland neoplasms with distinct biological behavior.

Authors:  Kelen Christine do Nascimento; Paulo Rogério de Faria; Luciano Lauria Dib; Maria Cássia Ferreira de Aguiar; Sérgio Vitorino Cardoso; Jucheng Chen; Adriano Mota Loyola
Journal:  Virchows Arch       Date:  2006-11-08       Impact factor: 4.064

7.  A human NDP-kinase B specifically binds single-stranded poly-pyrimidine sequences.

Authors:  M Hildebrandt; M L Lacombe; S Mesnildrey; M Véron
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

8.  Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate.

Authors:  S L Jensen; D P Wood; E R Banks; M Veron; I Lascu; J W McRoberts; V M Rangnekar
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

9.  Dictyostelium discoideum nucleoside diphosphate kinase C plays a negative regulatory role in phagocytosis, macropinocytosis and exocytosis.

Authors:  Sarah J Annesley; Ruzica Bago; Maja Herak Bosnar; Vedrana Filic; Maja Marinović; Igor Weber; Anil Mehta; Paul R Fisher
Journal:  PLoS One       Date:  2011-10-04       Impact factor: 3.240

10.  Extracellular NM23 Signaling in Breast Cancer: Incommodus Verum.

Authors:  Iain L O Buxton; Nucharee Yokdang
Journal:  Cancers (Basel)       Date:  2011-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.